ArticleAmerican heart journal2005

Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.

John J P Kastelein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.